Trial Profile
Study to evaluate the the safety and efficacy of oxycodone/naloxone in patients with parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 22 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.